- Home
- NVAX vs IAS Comparison
NVAX vs IAS Comparison
Compare NVAX & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- IAS
- Stock Information
- Founded
- NVAX 1987
- IAS 2009
- Country
- NVAX United States
- IAS United States
- Employees
- NVAX N/A
- IAS N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- IAS Computer Software: Programming Data Processing
- Sector
- NVAX Health Care
- IAS Technology
- Exchange
- NVAX Nasdaq
- IAS Nasdaq
- Market Cap
- NVAX 1.4B
- IAS 1.7B
- IPO Year
- NVAX 1995
- IAS 2021
- Fundamental
- Price
- NVAX $8.38
- IAS $10.68
- Analyst Decision
- NVAX Buy
- IAS Buy
- Analyst Count
- NVAX 6
- IAS 11
- Target Price
- NVAX $17.83
- IAS $14.80
- AVG Volume (30 Days)
- NVAX 4.8M
- IAS 687.8K
- Earning Date
- NVAX 02-26-2025
- IAS 02-25-2025
- Dividend Yield
- NVAX N/A
- IAS N/A
- EPS Growth
- NVAX N/A
- IAS 258.32
- EPS
- NVAX N/A
- IAS 0.20
- Revenue
- NVAX $885,193,000.00
- IAS $511,358,000.00
- Revenue This Year
- NVAX N/A
- IAS $11.97
- Revenue Next Year
- NVAX N/A
- IAS $11.92
- P/E Ratio
- NVAX N/A
- IAS $54.52
- Revenue Growth
- NVAX N/A
- IAS 11.77
- 52 Week Low
- NVAX $3.60
- IAS $7.98
- 52 Week High
- NVAX $23.86
- IAS $17.53
- Technical
- Relative Strength Index (RSI)
- NVAX 45.04
- IAS 61.04
- Support Level
- NVAX $8.30
- IAS $9.99
- Resistance Level
- NVAX $9.77
- IAS $10.63
- Average True Range (ATR)
- NVAX 0.56
- IAS 0.25
- MACD
- NVAX -0.06
- IAS 0.10
- Stochastic Oscillator
- NVAX 12.67
- IAS 96.46
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.